Contact: Camille Jewell, cjewell@vancomm.com or 202-248-5460 FAIRFAX, Va. — Guilherme Dabus, MD, an interventional neuroradiologist at the Baptist Health Miami Neuroscience Institute, has been named the 2025–2026 president of the Society of NeuroInterventional Surgery (SNIS), the world’s leading scientific and educational society dedicated to advancing the specialty of neurointerventional surgery. “Leading SNIS is both a
Study discusses how to mitigate damage from gunshot injuries to the brain in children and young adults
CONTACT: Camille Jewell, cjewell@vancomm.com or 202-248-5460 NASHVILLE — A study presented today at the Society of NeuroInterventional Surgery’s (SNIS) 22nd Annual Meeting found that almost half of gunshot wound injuries to the brain in children and young adults include penetrating cerebrovascular injuries (PCVIs). These types of injuries, which damage blood vessels in the brain
MicroVention Announces First Patient Enrolled in the STRAIT Study with the New BOBBY™ Balloon Guide Catheter
Aliso Viejo, CA – April 20, 2022 – MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a multi-center, prospective EU observational study called STRAIT, to evaluate the Safety and Performance of the BOBBY Balloon Guide Catheter for Endovascular Treatment of Acute Ischemic Stroke. The BOBBY
Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Approval of the PMA Supplement for the WEB 17 System, a new addition to the WEB Aneurysm Embolization System for the treatment of intracranial wide neck bifurcation aneurysms. The WEB 17 System, designed with the latest microbraid technology, features
MIVI Neuroscience Receives IDE to Study Q Aspiration Catheter
MIVI Neuroscience announced that the FDA has approved an investigational device exemption to initiate a human clinical study of the MIVI Q aspiration catheter in the United States. EVaQ is a prospective, multicenter, single-arm study of the Q revascularization system for neurointervention in acute ischemic stroke. According to the company, the study will assess the
MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms
MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms. The FRED® device is the first flow diverter in the U.S. to use a self-expanding braided nitinol mesh to help re-direct blood